IMMP
Immutep LimitedNASDAQHealthcare$0.36-2.30%ClosedMarket Cap: $53.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.65
P/S
10.85
EV/EBITDA
0.07
DCF Value
$0.17
FCF Yield
-96.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
-522.6%
Operating Margin
-2052.2%
Net Margin
-1404.1%
ROE
-69.2%
ROA
-57.0%
ROIC
-122.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $6.0M | -673.6% | $-46.0M | $-44.9M | $-0.30 | — |
| Q4 2025 | $1.9M | -1802.8% | $-74.7M | $-39.1M | $-0.27 | — |
| FY 2025 | $5.0M | -1117.6% | $-126.4M | $-61.4M | $-0.42 | — |
| Q2 2025 | $3.1M | -704.7% | $-51.7M | $-22.4M | $-0.15 | — |
| Q4 2024 | $1.7M | -1119.4% | $-44.5M | $-21.5M | $-0.18 | — |
| FY 2024 | $3.8M | -981.4% | $-88.1M | $-42.7M | $-0.36 | — |
| Q2 2024 | $2.1M | 52.8% | $-43.6M | $-21.2M | $-0.18 | — |
| Q4 2023 | $1.8M | 49.2% | $-21.8M | $-19.3M | $-0.21 | — |
| FY 2023 | $3.5M | 41.2% | $-77.7M | $-39.9M | $-0.44 | — |
| Q2 2023 | $1.7M | 44.5% | $-23.1M | $-20.6M | $-0.23 | — |
| Q4 2022 | $170.4K | -555.5% | $-19.5M | $-15.9M | $-0.18 | — |
| FY 2022 | $170.4K | -1111.2% | $-33.9M | $-32.2M | $-0.37 | — |